Infection-Related Malignant Neoplasm — Trials

Infection-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 133
Recruiting: 71
Ph III recruiting: 2
Growth YoY: −24%
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (75)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05882305	KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial	withdrawn	Early Phase 1	0	Kousai Bio Co., Ltd.OTHER	1	Oct 30, 2024	clinicaltrials

Data updated 23 days agoSource updated Oct 30, 2024source: clinicaltrials